FDA Inspection 1081243 — Oklahoma Blood Institute Arkansas Blood Institute
The FDA completed an inspection of Oklahoma Blood Institute Arkansas Blood Institute on Feb 6, 2019 in Russellville, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 6, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Russellville, AR (United States)